McNamara Timothy 4

Accession 0001181431-12-031810

CIK 0000930553other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 8:01 PM ET

Size

39.0 KB

Accession

0001181431-12-031810

Insider Transaction Report

Form 4

Period: 2012-05-18

ISTA PHARMACEUTICALS INCISTA

McNamara Timothy

VP Clinical Research & Medical

Transactions

Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−12,752$115,661→ 6,750 total
Exercise: $1.04From: 2009-03-03Exp: 2019-02-03→ Common Stock (12,752 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−13,056$118,418→ 0 total
Exercise: $6.77From: 2006-03-16Exp: 2016-02-16→ Common Stock (13,056 underlying)
Tax Payment
Common Stock
2012-05-18$9.07/sh−5,103$46,284→ 89,688 total
Exercise/Conversion
Common Stock
2012-05-18$6.82/sh+4,298$29,312→ 93,986 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−11,084$100,532→ 0 total
Exercise: $4.46From: 2008-03-08Exp: 2018-02-08→ Common Stock (11,084 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−19,934$180,801→ 0 total
Exercise: $6.42From: 2006-12-17Exp: 2016-11-17→ Common Stock (19,934 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−4,298$38,983→ 25,073 total
Exercise: $6.82From: 2011-03-07Exp: 2021-02-07→ Common Stock (4,298 underlying)
Exercise/Conversion
Common Stock
2012-05-18$3.63/sh+12,750$46,283→ 94,791 total
Tax Payment
Common Stock
2012-05-18$9.07/sh−9,745$88,387→ 58,064 total
Exercise/Conversion
Common Stock
2012-05-18$6.42/sh+19,934$127,976→ 77,998 total
Tax Payment
Common Stock
2012-05-18$9.07/sh−14,110$127,978→ 63,888 total
Exercise/Conversion
Common Stock
2012-05-18$7.43/sh+6,795$50,487→ 70,683 total
Tax Payment
Common Stock
2012-05-18$9.07/sh−5,566$50,484→ 65,117 total
Exercise/Conversion
Common Stock
2012-05-18$4.46/sh+11,084$49,435→ 76,201 total
Tax Payment
Common Stock
2012-05-18$9.07/sh−5,450$49,432→ 70,751 total
Exercise/Conversion
Common Stock
2012-05-18$1.04/sh+12,752$13,262→ 83,503 total
Tax Payment
Common Stock
2012-05-18$9.07/sh−1,462$13,260→ 82,041 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−6,795$61,631→ 0 total
Exercise: $7.43From: 2007-03-02Exp: 2017-02-02→ Common Stock (6,795 underlying)
Tax Payment
Common Stock
2012-05-18$9.07/sh−3,232$29,314→ 90,754 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18$9.07/sh−12,750$115,643→ 15,750 total
Exercise: $3.63From: 2010-03-02Exp: 2020-02-02→ Common Stock (12,750 underlying)
Exercise/Conversion
Common Stock
2012-05-18$6.77/sh+13,056$88,389→ 67,809 total

Footnotes (1)

[F1]Mr. McNamara exercised options for 80,669 of Issuer's shares under his Employee Stock Option (as shown in Table II of this Form 4). Of that amount, Mr. McNamara elected to have the Issuer withhold 44,668 shares to cover the exercise price in connection with the exercise of his Employee Stock Option (as shown in Table II of the Form 4). Mr. McNamara continues to hold the net remaining amount of 36,001 shares.

Documents

1 file

4
rrd346292.xmlPrimary
FORM 4

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

→

Entity typeother

Related Parties

filerCIK 0001381689

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 8:01 PM ET
Size: 39.0 KB

View on SEC.gov